Clinical stage I (CSI) testicular germ cell tumors (TGCT) represents disease confined to the testis without metastasis and CSIS is defined as persistently elevated tumor markers (TM) after orchiectomy, indicating subclinical metastatic disease.
(UroToday.com) The Society of Urologic Oncology (SUO) 2021 annual meeting in Orlando, FL hosted a special presentation by Dr. Kenneth G. Nepple, MD that addressed the importance of health information technology to improve clinical processes and patient care. Although Dr. Nepple is still a practicing urologic oncologist, he has assumed many administrative and leadership tasks within […]
(UroToday.com) The Society of Urologic Oncology (SUO) 2021 annual meeting in Orlando, FL included an overview of molecular classification of upper tract urothelial carcinoma (UTUC), presented by Dr. Jonathan Coleman, MD, Associate Professor at the Memorial Sloan Kettering Cancer Center in New York, NY.
(UroToday.com) The Society of Urologic Oncology (SUO) 2021 annual meeting in Orlando, FL hosted an overview of integrating somatic and germline next generation sequencing results into the clinical management of patients with advanced prostate cancer, presented by Dr. Kara N. Maxwell, MD, PhD.
Investigate the impact of urinary incontinence (UI) on quality of life (QoL) in female CrossFit practitioners and to verify the strategies used by them to minimize the occurrence of urine leakage. In addition, to verify whether anthropometric and clinical characteristics increase the UI impact on QoL of female CrossFit practitioners.
The aim of this study was to evaluate changes in the quality of life with the connected biofeedback EMY Kegel trainer in patients suffering from stress urinary incontinence. Materiel and methods: This was a prospective, single-center, non-comparative study, which took place between September 2019 and October 2020, in the University Hospitals of Strasbourg.
Although specialists are skilled in the management of urinary incontinence, primary care clinicians are integral in early diagnosis and initiation of management in order to decrease overuse of specialty care and improve the quality of specialist visits.
To develop and validate a prediction model for bothersome stress urinary incontinence after prolapse surgery and to compare it to an existing clinical prediction model (CUPIDO model). Retrospective cohort study SETTING: Two tertiary hospitals in South Korea POPULATION: A total of 1,142 patients who underwent prolapse surgery with or without a concomitant midurethral sling.
The aim of this study was to investigate the longitudinal 5-year long-term outcomes for urinary continence and quality of life (QOL) after robot-assisted radical prostatectomy (RARP), particularly nerve-sparing.
Develop models to predict outcomes after intradetrusor injection of 100 or 200 units of onabotulinumtoxinA in women with non-neurogenic urgency urinary incontinence (UUI). Models were developed using 307 women from two randomized trials assessing efficacy of onabotulinumtoxinA for non-neurogenic UUI.
